Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

7 recruiting

Enrollment Performance

Analytics

Phase 1
5(62.5%)
Phase 2
3(37.5%)
8Total
Phase 1(5)
Phase 2(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT07284641Phase 2Recruiting

Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD)

Role: lead

NCT04528355Recruiting

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Role: lead

NCT03500731Phase 1Recruiting

Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

Role: lead

NCT01962415Phase 2Recruiting

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Role: lead

NCT01852370Phase 1Enrolling By Invitation

Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases

Role: lead

NCT00692939Phase 1Recruiting

Autologous Stem Cell Transplantation for Crohn's Disease

Role: lead

NCT03630211Phase 2Recruiting

Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis

Role: lead

NCT03653338Phase 1Recruiting

T-Cell Depleted Alternative Donor Bone Marrow Transplant for Sickle Cell Disease (SCD) and Other Anemias

Role: lead

NCT06027879Phase 1Enrolling By Invitation

Anti-viral T-cell Therapy by Gamma Capture

Role: lead

All 9 trials loaded